We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TME:NYSETencent Music Entertainment Group Analysis

Data as of 2026-03-11 - not real-time

$13.96

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Tencent Music (TME) is trading at $13.96, well below its 20‑day SMA of $14.86, 50‑day SMA of $16.13 and 200‑day SMA of $19.95, indicating a clear bearish price trend. Fundamentally, the stock appears deeply undervalued – its trailing P/E of 13.8 is below the industry average of 18.2, price‑to‑sales is only 0.74, and the DCF‑derived fair value of $114.35 suggests over 90% upside potential. The company delivers strong profitability (gross margin 44%, operating margin 29%, profit margin 34%) and robust cash generation (free cash flow $5.38 B, payout ratio under 20%), supporting a sustainable dividend of 1.29%.
Recent news highlights a strategic shift from virtual gifting to paid subscription revenue, which could stabilize earnings as China’s paid music market expands. While competition is intensifying and margins face pressure, the upcoming Q4/2025 earnings release on March 17 will be a key catalyst. Given the low valuation, strong cash position, and significant upside, the stock warrants a bullish stance despite short‑term technical weakness.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near technical support at $13.35
  • Oversold RSI (~34) suggesting bounce potential
  • Upcoming earnings report could confirm revenue shift

Medium Term

1–3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong cash balance versus debt (net cash > $18 B)
  • Valuation multiples well below peers and DCF fair value
  • Revenue growth of 20% driven by subscription expansion

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend supported by free cash flow
  • Dominant market position in China’s music streaming ecosystem
  • Long‑term tailwinds from paid music, podcasts and live streaming

Key Metrics & Analysis

Financial Health

Revenue Growth20.60%
Profit Margin34.08%
P/E Ratio13.8
ROE14.79%
ROA7.84%
Debt/Equity4.52
P/B Ratio1.8
Op. Cash Flow$10.3B
Free Cash Flow$5.4B
Industry P/E18.2

Technical Analysis

TrendBearish
RSI34.5
Support$13.35
Resistance$17.18
MA 20$14.86
MA 50$16.13
MA 200$19.95
MACDBearish
VolumeStable
Fear & Greed Index76.61

Valuation

Fair Value$114.35
Target Price$26.56
Upside/Downside90.28%
GradeUndervalued
TypeBlend
Dividend Yield1.29%

Risk Assessment

Beta0.86
Volatility45.38%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.